Carter's (CRI) Tops Q4 EPS by 34c, Beats on Revenue; Offers Guidance

Carter's (NYSE: CRI) reported Q4 EPS of $1.90, $0.34 better than the analyst estimate of $1.56. Revenue for the quarter came in at $925 million versus the consensus estimate of $903.84 million.

For fiscal year 2026 (a 52 week fiscal year), the Company projects approximately:

Low single-digit to mid-single-digit percentage growth in net sales ($2.898 billion in fiscal 2025);
Low single-digit to mid-single-digit growth in adjusted operating income ($176 million in fiscal 2025);
Low double-digit to mid-teens decline in adjusted diluted earnings per share ($3.47 in fiscal 2025);
Operating cash flow of $110 million to $120 million; and
Capital expenditures of $55 million.

For earnings history and earnings-related data on Carter's (CRI) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
• Japan's Katayama, Us Treasury's Bessent Hold Online Talks, Source Says - Reuters